Cognitive Behavioral Therapy for Insomnia
BehavioralCognitive-Behavioural Therapy for Insomnia (CBT-I) includes behavioral methods, cognitive methods, and sleep hygiene counselling.
Other names: CBT-I
NCT Number: NCT06827626
The goal of this clinical trial is to evaluate the usefulness of cognitive behavioural therapy for insomnia (CBT-I) tailored to shift workers in the social and health care sector. The study will also learn about the shift workers' experiences of the acceptability and feasibility of CBT-I and investigate which features of shift work and individual characteristics promote or interfere with the effectiveness of the tailored CBT-I.
The main question the study aims to answer is:
• Does CBT-I tailored to shift workers in the social and health care sector improve perceived insomnia severity, insomnia symptoms, mental health and quality of life?
Researchers will compare CBT-I to a control intervention (short sleep hygiene counselling) to see if CBT-I works to treat insomnia in shift workers.
Participants will:
* Participate in the research intervention (CBT-I tailored to the shift work context; six individual sessions) or the control intervention (sleep hygiene counselling; one individual session) * Complete the measures (sleep diary, actigraphy and questionnaires) at baseline, after the end of treatment (12 weeks after the first session) and at 6 months after the end of treatment.
This study is active but is not currently recruiting participants.
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Terveystalo Oyj, Helsinki, Uusima, Finland
Disturbed sleep and insomnia are common among shift workers, and disturbed sleep is considered a key factor in other health risks associated with shift work. However, there are no established treatment practices for treating insomnia in shift workers. This study aims to evaluate the effectiveness of Cognitive-Behavioural Therapy for Insomnia (CBT-I) tailored for social and health care sector shift workers whose work includes night shifts. Furthermore, the study will assess the shift workers' experiences of the acceptability and feasibility of CBT-I from their perspective. The study will also examine which features of shift work and employee characteristics promote or interfere with the effectiveness of the tailored CBT-I.
The study is a randomised controlled trial. Participants will be shift workers in the social and health care sector who work in three or two shifts, including night shifts, and have significant insomnia symptoms. Participants will be recruited through occupational health services (OHS) and social media posts. The FIOH study group will carry out the measurements of the participants. Participants will complete the baseline measures (sleep diary, actigraphy and questionnaires) and then will be randomly assigned to receive the research intervention (CBT-I tailored to the shift work context; six individual sessions) or the control intervention (sleep hygiene counselling; one individual session). The interventions will be delivered by the nurses of the participants´ OHS and the FIOH. Participants will complete the follow-up measures after the end of treatment (12 weeks after the first session) and at 6 months after the end of treatment.
The results of the study can be utilised in OHS to guide and treat shift workers with insomnia as part of supporting their work ability.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cognitive-Behavioural Therapy for Insomnia (CBT-I) includes behavioral methods, cognitive methods, and sleep hygiene counselling.
Other names: CBT-I
Sleep hygiene counselling includes common instructions to improve sleep.
Other names: Sleep hygiene
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
Insomnia Severity Index (ISI) contains seven items about insomnia during the last month [item scale 0 (not at all) -4 (very severe)]. The sum of the scores serves as the ISI score.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
Insomnia symptoms are assessed by sleep diary. It is completed using a mobile phone app (Experience Sampling Platform - movisensXS - movisens GmbH). The sleep diary contains questions about the timing of the sleep period, sleep onset latency, wake after sleep onset, number of awakenings after sleep onset, sleep quality, time spent in bed, restedness after sleep, use of sleep-promoting medication, working times, recovery from work, naps and their timing. Total sleep time and sleep efficiency are calculated from the responses. The averages will serve as the outcomes. Participants will keep the sleep diary for 1-2 weeks at each measurement period.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
Insomnia symptoms are also assessed using the Actigraphy Link GT9X. Actigraphy recording is conducted for 1-2 weeks at the same time as the sleep diary. From the actigraphy data, we analyse sleep onset latency, wake after sleep onset, total sleep time, sleep efficiency, naps and their timing. The averages will serve as the outcomes.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
Shift-specific questions on insomnia and sleepiness (SS-Q) -questionnaire measures separately sleepiness and insomnia symptoms in three different shifts (morning, evening and night shifts) and while on holiday over two weeks [item scale 1 (never) - 5 (always)]. Shift work disorder (SWD) cases has to report sleepiness and/or insomnia "never" or "rarely" while on holiday and the never or rarely occurring symptom "often" or "always" in connection to some shift type/types. SWD score [0 (no SWD) or 1(SWD case)] is used as outcome.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
The Ford Insomnia Response to Stress Test (FIRST) contains nine items about insomnia reactivity in potentially stressful situations [item scale 1 (not likely) - 4 (very likely)]. The sum of the scores serves as the FIRST score.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
Sleep-related Beliefs and Attitudes about Sleep (DBAS-16) -questionnaire contains 16 items to assesses sleep-related dysfunctional cognitions [item scale 0 (strongly disagree) - 10 (strongly agree)]. The average of the scores serve as the DBAS score.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
The Epworth Sleepiness Scale (ESS) contains eight items to measure the subject's general level of daytime sleepiness in different situations [item scale 0 (would never nod off) - 3 (high chance of nodding off)]. The sum of the scores serves as the ESS score.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
The Patient Health Questionnaire (PHQ-9) contains nine items to measure depression severity [item scale 0 (not at all) - 3 (nearly every day)]. The sum of the scores serves as the PHQ-9 score.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
The GAD-7 contains seven items measuring the severity of the symptoms of generalised anxiety disorder [item scale 0 (not at all) - 3 (nearly every day)]. The sum of the scores serves as the GAD-7 score.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
The Burnout Assessment Tool (BAT-12) contains 12 items measuring burnout symptoms [item scale 1 (never) - 5 (always)]. The average of the scores serves as the BAT-12 score.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
EuroHIS-8 contains 8 items measuring the quality of life [item scale 1 (worst outcome) - 5 (best outcome)]. The sum of the scores serves as the EUROHIS-8 score.
Power, M. (2003). Development of a common instrument for quality of life. In A. Nosikov & C. Gudex (edit.), EUROHIS: Developing Common Instruments for Health Surveys (145-159). Amsterdam, Holland: IOS Press.
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
Work ability measure includes an item measuring self-rated work ability (item scale 0 (not at all) - 10 (very good)].
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
The recovery measure includes an item measuring recovery from work [item scale 1 (badly) - 5 (well)]. In this study, recovery is measured separately in four different shifts (morning, day, evening and night shifts).
Time frame: After the end of treatment (12 weeks after the first session)
Participants' experiences of the implementation of the interventions are assessed using the Acceptability of Intervention Measure, the Intervention Appropriateness Measure, and the Feasibility of Intervention Measure [each with four items and a scale 1 (completely disagree) - 5 (completely agree)]. The average of each measure serves as a acceptability, appropriateness and feasibility measure of implementation.
Time frame: After the end of treatment (12 weeks after the first session)
Participants rate the global effectiveness of the treatment in improving their overall life situation and well-being using a question from the Consumer Reports survey [item scale 1 (not at all) - 7 (decisive impact)].
Time frame: From baseline to the end of treatment (12 weeks after the first session) and to the 6 months after the end of treatment.
Questions about age, gender, marital status, educational level, shift work related issues (e.g. shift schedules and number of different shifts per month), comorbid conditions, medications and chronotype.
Time frame: After each intervention session
Participants assess perceived helpfulness and feasibility of each treatment session on a rating scale from 0 (not at all helpful/easy) to 100 (extremely helpful/easy) and answers open-questions about helpfulness and feasibility.
Finnish Institute of Occupational Health
Other
Acronym: Sote-VURHOT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04253691
Chronic Pain, Dyssomnias
Columbia, Missouri, United States
View Trial DetailsNCT05373537
Autism Spectrum Disorder, Behavior
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT05244889
Brain Diseases, Central Nervous System Diseases
Glasgow, United Kingdom
View Trial DetailsNCT04627480
Dyssomnias, Insomnia
New York, United States
View Trial Details